A DLL3/CD3/CD137 trispecific T cell engager shows potent antitumor activity in small cell lung cancer models

被引：2
|
作者：
Mikami, Hirofumi
Feng, Shu
Naoi, Sotaro
Azuma, Yumiko
Kayukawa, Yoko
Tsunenari, Toshiaki
Asanuma, Kentaro
Iwabuchi, Ryutaro
Nagano, Hiroaki
Shinozuka, Junko
Yamazaki, Masaki
Kuroi, Haruka
Gan, Siok Wan
Chichili, Priyanka
Shimizu, Shun
Matsuda, Yutaka
Ishii, Shinya
Kamikawaji, Shogo
Kinoshita, Yasuko
Shimizu, Yuichiro
Sakamoto, Akihisa
Muraoka, Masaru
Takahashi, Noriyuki
Kawa, Tatsuya
Shiraiwa, Hirotake
Kashima, Kenji
Mimoto, Futa
Kamata-Sakurai, Mika
Kitazawa, Takehisa
Igawa, Tomoyuki
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1872
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1872
引用
收藏
页数：3
相关论文
共 50 条
  • [31] DLL3 Expression in Small Cell Lung Carcinomas (SCLC)
    Odashiro, Patricia
    Tomarchio, Gloria
    Gagne, Andreanne
    Orain, Michele
    Desmeules, Patrice
    Joubert, Philippe
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1809 - 1810
  • [32] Targeting DLL3 in Small-Cell Lung Cancer with Novel Modalities
    Poirier, J. T.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S8 - S8
  • [33] Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer
    Isobe, Yoshitaka
    Sato, Kazuhide
    Nishinaga, Yuko
    Takahashi, Kazuomi
    Taki, Shunichi
    Yasui, Hirotoshi
    Shimizu, Misae
    Endo, Rena
    Koike, Chiaki
    Kuramoto, Noriko
    Yukawa, Hiroshi
    Nakamura, Shota
    Fukui, Takayuki
    Kawaguchi, Koji
    Chen-Yoshikawa, Toyofumi F.
    Baba, Yoshinobu
    Hasegawa, Yoshinori
    EBIOMEDICINE, 2020, 52
  • [34] HPN328: An anti-DLL3 T cell engager for treatment of small cell lung cancer
    Aaron, Wade H.
    Austin, Richard
    Barath, Manasi
    Callihan, Evan
    Cremin, Michael
    Evans, Thomas
    Gamez, Maria
    Ganti, Vaishnavi
    Hemmati, Golzar
    Kwant, Kathryn
    Law, Che-Leung
    Lemon, Bryan
    Lao, Llewelyn
    Molloy, Mary Ellen
    O'Rear, Jessica
    Sun, Laura
    Wesche, Holger
    Yu, Stephen
    Yu, Timothy
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [35] Antitumor activity of a ROR1 x CD3 bispecific antibody in non-small cell lung cancer
    Wang, Yi
    Zhang, Yuxi
    Sun, Haoyi
    Chen, Jilan
    Yang, Hui
    Zhong, Zhanqiong
    Xiao, Xiaoqian
    Li, Yanping
    Tang, Yibei
    Lu, Haolan
    Tang, Xinzhi
    Zhang, Mengyang
    Wu, Wenjun
    Zhou, Shiyi
    Yang, Jiahui
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 123
  • [36] Near Infrared Photoimmunotherapy Targeting DLL3 Against Small Cell Lung Cancer
    Isobe, Y.
    Sato, K.
    Takahashi, K.
    Taki, S.
    Yasui, H.
    Nishinaga, Y.
    Matsui, T.
    Hasegawa, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S536 - S537
  • [37] Rovalpituzumab tesirine and DLL3: a new challenge for small-cell lung cancer
    Rossi, Antonio
    LANCET ONCOLOGY, 2017, 18 (01): : 3 - 5
  • [38] Antitumor activity of AMG757, a half-life extended (HLE) bispecific T-cell engager (BiTE®) immune therapy targeting DLL3, in human PDX and orthotopic mouse models of small cell lung cancer (SCLC)
    Cooke, Keegan
    Estrada, Juan
    Zhan, Jinghui
    Werner, Jonathan
    Caenepeel, Sean
    Giffin, Mike
    Bailis, Julie M.
    Coxon, Angela
    Hughes, Paul E.
    Canon, Jude
    CANCER RESEARCH, 2020, 80 (16)
  • [39] DLL3 regulates the migration and invasion of small cell lung cancer by modulating Snail
    Furuta, Megumi
    Kikuchi, Hajime
    Shoji, Tetsuaki
    Takashima, Yuta
    Kikuchi, Eiki
    Kikuchi, Junko
    Kinoshita, Ichiro
    Dosaka-Akita, Hirotoshi
    Sakakibara-Konishi, Jun
    CANCER SCIENCE, 2019, 110 (05) : 1599 - 1608
  • [40] Characterization of the CD3ζ, CD3γδ and CD3ε subunits of the T cell receptor complex in Atlantic salmon
    Liu, Yun
    Moore, Lindsey
    Koppang, Erling Olaf
    Hordvik, Ivar
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2008, 32 (01): : 26 - 35
12345